Alopecia totalis

Last updated
Alopecia totalis
AlopeciaTotalis.jpg
A woman with alopecia totalis
Specialty Dermatology   OOjs UI icon edit-ltr-progressive.svg

Alopecia totalis is the loss of all hair on the head and face. Its causes are unclear, but it is believed to be an autoimmune disorder. Research suggests there may be a genetic link: the presence of DRB1*0401 and DQB1*0301, both of which are human leukocyte antigens (HLA), have been found to be associated with long-standing alopecia totalis. [1]

Contents

Treatment

Methotrexate and corticosteroids are proposed treatments. [2]

Scalp cooling has specifically been used to prevent alopecia in docetaxel chemotherapy, [3] although it has been found prophylactic in other regimens as well. [4] [5] [6] Treatment effects may take time to resolve, with one study showing breast cancer survivors wearing wigs up to 2 years after chemotherapy. [7]

See also

References

  1. ↑ Colombe, Beth W.; Lou, Calvin D.; Price, Vera H. (December 1999). "The Genetic Basis of Alopecia Areata: HLA Associations with Patchy Alopecia Areata Versus Alopecia Totalis and Alopecia Universalis". Journal of Investigative Dermatology Symposium Proceedings. 4 (3): 216–219. doi: 10.1038/sj.jidsp.5640214 . ISSN   1087-0024. PMID   10674369.
  2. ↑ Joly, Pascal (2006). "The use of methtrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis". Journal of the American Academy of Dermatology. 55 (4): 632–6. doi:10.1016/j.jaad.2005.09.010. PMID   17010743.
  3. ↑ Hurk, C. J. G.; Breed, W. P. M.; Nortier, J. W. R. (2012). "Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia". Supportive Care in Cancer. 20 (12): 3255–3260. doi:10.1007/s00520-012-1465-0. PMID   22539051. S2CID   1282047.
  4. ↑ Lemieux, J. (2012). "Reducing chemotherapy-induced alopecia with scalp cooling". Clinical Advances in Hematology & Oncology. 10 (10): 681–682. PMID   23187775.
  5. ↑ Van Den Hurk, C. J.; Peerbooms, M.; Van De Poll-Franse, L. V.; Nortier, J. W.; Coebergh, J. W. W.; Breed, W. P. (2012). "Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - Results of the Dutch Scalp Cooling Registry". Acta Oncologica. 51 (4): 497–504. doi:10.3109/0284186X.2012.658966. PMID   22304489. S2CID   26709009.
  6. ↑ Yeager, C. E.; Olsen, E. A. (2011). "Treatment of chemotherapy-induced alopecia". Dermatologic Therapy. 24 (4): 432–442. doi:10.1111/j.1529-8019.2011.01430.x. PMID   21910801. S2CID   45148677.
  7. ↑ Oshima, Y.; Watanabe, T.; Nakagawa, S.; Endo, A.; Shiga, C. (2012). "A questionnaire survey about hair loss after chemotherapy for breast cancer". Gan to Kagaku Ryoho. Cancer & Chemotherapy. 39 (9): 1375–1378. PMID   22996772.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.